Ascendis Pharma A/S (ASND)
230.70
+7.57
(+3.39%)
USD |
NASDAQ |
Sep 24, 16:00
234.25
+3.55
(+1.54%)
After-Hours: 06:05
Ascendis Pharma Gross Profit (Annual) : 691.49M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 691.49M |
| December 31, 2024 | 333.14M |
| December 31, 2023 | 225.11M |
| December 31, 2022 | 25.69M |
| December 31, 2021 | -10.11M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 19.47M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| BioMarin Pharmaceutical, Inc. | 2.505B |
| Novo Nordisk A/S | 37.55B |
| Evaxion AS | 0.00 |
| Genmab A/S | 3.421B |
| Zealand Pharma A/S | 1.389B |